HEADER TRANSFERASE 10-MAR-05 1WZY TITLE CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A PYRAZOLOPYRIDAZINE TITLE 2 DERIVATIVE COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOGEN-ACTIVATED PROTEIN KINASE 1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: EXTRACELLULAR SIGNAL-REGULATED KINASE 2, ERK-2, MITOGEN- COMPND 5 ACTIVATED PROTEIN KINASE 2, MAP KINASE 2, MAPK 2, P42-MAPK, ERT1; COMPND 6 EC: 2.7.1.37; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS ERK2, INHIBITOR, KINASE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR T.KINOSHITA REVDAT 4 13-MAR-24 1WZY 1 REMARK SEQADV REVDAT 3 11-OCT-17 1WZY 1 REMARK REVDAT 2 24-FEB-09 1WZY 1 VERSN REVDAT 1 20-DEC-05 1WZY 0 JRNL AUTH T.KINOSHITA,M.WARIZAYA,M.OHORI,K.SATO,M.NEYA,T.FUJII JRNL TITL CRYSTAL STRUCTURE OF HUMAN ERK2 COMPLEXED WITH A JRNL TITL 2 PYRAZOLO[3,4-C]PYRIDAZINE DERIVATIVE JRNL REF BIOORG.MED.CHEM.LETT. V. 16 55 2006 JRNL REFN ISSN 0960-894X JRNL PMID 16242327 JRNL DOI 10.1016/J.BMCL.2005.09.055 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNX 2002 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA, REMARK 3 : YIP,DZAKULA) REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 11.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 267681.620 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.7 REMARK 3 NUMBER OF REFLECTIONS : 12725 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.253 REMARK 3 R VALUE (WORKING SET) : 0.249 REMARK 3 FREE R VALUE : 0.292 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 653 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.011 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA. REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL REMARK 3 FREE R VALUE (NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 12874 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.70 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 1993 REMARK 3 BIN R VALUE (WORKING SET) : 0.2280 REMARK 3 BIN FREE R VALUE : 0.2760 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.70 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 98 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.028 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2847 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 28 REMARK 3 SOLVENT ATOMS : 241 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 19.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 23.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.92000 REMARK 3 B22 (A**2) : 1.94000 REMARK 3 B33 (A**2) : 0.98000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -1.19000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.33 REMARK 3 ESD FROM SIGMAA (A) : 0.16 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.39 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.14 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.007 REMARK 3 BOND ANGLES (DEGREES) : 1.700 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.30 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.050 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 1.590 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.650 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 1.990 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 2.880 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : BABINET REMARK 3 KSOL : NULL REMARK 3 BSOL : 280.0 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : FR296110.X.PARAM REMARK 3 PARAMETER FILE 4 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 TOPOLOGY FILE 4 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: RESOLUTION-DEPENDENT WEIGHTING SCHEME, REMARK 3 BULK SOLVENT MODEL USED REMARK 4 REMARK 4 1WZY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 11-MAR-05. REMARK 100 THE DEPOSITION ID IS D_1000024205. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 20-DEC-04 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SPRING-8 REMARK 200 BEAMLINE : BL32B2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00 REMARK 200 MONOCHROMATOR : GRAPHITE REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS REMARK 200 INTENSITY-INTEGRATION SOFTWARE : R-AXIS REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR (MSC/RIGAKU) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 12848 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 45.590 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.41 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 5000, AMMONIUM SULPHATE, REMARK 280 DITHIOTHREITOL, PH 6.5, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.27050 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A -7 REMARK 465 ASP A -6 REMARK 465 LEU A -5 REMARK 465 GLY A -4 REMARK 465 SER A -3 REMARK 465 ASP A -2 REMARK 465 GLU A -1 REMARK 465 LEU A 0 REMARK 465 MET A 1 REMARK 465 ALA A 2 REMARK 465 ALA A 3 REMARK 465 ALA A 4 REMARK 465 ALA A 5 REMARK 465 ALA A 6 REMARK 465 ALA A 7 REMARK 465 TYR A 358 REMARK 465 ARG A 359 REMARK 465 SER A 360 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 9 -150.31 -121.10 REMARK 500 VAL A 14 -84.24 -130.14 REMARK 500 PHE A 19 73.26 -117.52 REMARK 500 GLU A 33 -70.45 -52.77 REMARK 500 ALA A 35 -113.14 63.04 REMARK 500 PRO A 58 -131.86 -79.77 REMARK 500 PHE A 59 -30.28 77.45 REMARK 500 MET A 108 -85.19 -86.48 REMARK 500 GLU A 109 -54.42 173.64 REMARK 500 ASP A 149 38.75 -161.04 REMARK 500 ASN A 158 -163.24 -104.04 REMARK 500 CYS A 166 -57.84 -125.93 REMARK 500 ALA A 174 -86.84 -35.20 REMARK 500 ASP A 175 66.49 72.85 REMARK 500 LEU A 184 87.18 30.12 REMARK 500 GLU A 186 164.41 62.13 REMARK 500 TYR A 187 97.80 179.61 REMARK 500 ALA A 189 -47.66 -155.12 REMARK 500 THR A 190 79.94 71.65 REMARK 500 ARG A 191 -165.70 -171.91 REMARK 500 TRP A 192 -5.88 -142.94 REMARK 500 LEU A 200 -85.50 -75.62 REMARK 500 PRO A 229 -72.19 -102.05 REMARK 500 LYS A 231 107.25 59.63 REMARK 500 HIS A 232 -152.05 -101.04 REMARK 500 TYR A 233 -120.72 11.73 REMARK 500 ILE A 256 54.28 -92.38 REMARK 500 PHE A 279 74.24 -119.54 REMARK 500 PRO A 280 -70.42 -31.58 REMARK 500 ASP A 318 88.84 -160.87 REMARK 500 GLU A 322 69.79 -152.61 REMARK 500 ALA A 325 -83.19 -22.22 REMARK 500 GLU A 326 -45.72 111.80 REMARK 500 LYS A 330 63.58 -176.94 REMARK 500 GLU A 334 141.59 -22.64 REMARK 500 LEU A 335 74.47 55.08 REMARK 500 ASP A 336 -128.55 42.99 REMARK 500 LEU A 338 118.07 -173.54 REMARK 500 PRO A 356 101.22 -41.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE F29 A 1001 DBREF 1WZY A 1 360 UNP P28482 MK01_HUMAN 1 360 SEQADV 1WZY GLY A -7 UNP P28482 CLONING ARTIFACT SEQADV 1WZY ASP A -6 UNP P28482 CLONING ARTIFACT SEQADV 1WZY LEU A -5 UNP P28482 CLONING ARTIFACT SEQADV 1WZY GLY A -4 UNP P28482 CLONING ARTIFACT SEQADV 1WZY SER A -3 UNP P28482 CLONING ARTIFACT SEQADV 1WZY ASP A -2 UNP P28482 CLONING ARTIFACT SEQADV 1WZY GLU A -1 UNP P28482 CLONING ARTIFACT SEQADV 1WZY LEU A 0 UNP P28482 CLONING ARTIFACT SEQRES 1 A 368 GLY ASP LEU GLY SER ASP GLU LEU MET ALA ALA ALA ALA SEQRES 2 A 368 ALA ALA GLY ALA GLY PRO GLU MET VAL ARG GLY GLN VAL SEQRES 3 A 368 PHE ASP VAL GLY PRO ARG TYR THR ASN LEU SER TYR ILE SEQRES 4 A 368 GLY GLU GLY ALA TYR GLY MET VAL CYS SER ALA TYR ASP SEQRES 5 A 368 ASN VAL ASN LYS VAL ARG VAL ALA ILE LYS LYS ILE SER SEQRES 6 A 368 PRO PHE GLU HIS GLN THR TYR CYS GLN ARG THR LEU ARG SEQRES 7 A 368 GLU ILE LYS ILE LEU LEU ARG PHE ARG HIS GLU ASN ILE SEQRES 8 A 368 ILE GLY ILE ASN ASP ILE ILE ARG ALA PRO THR ILE GLU SEQRES 9 A 368 GLN MET LYS ASP VAL TYR ILE VAL GLN ASP LEU MET GLU SEQRES 10 A 368 THR ASP LEU TYR LYS LEU LEU LYS THR GLN HIS LEU SER SEQRES 11 A 368 ASN ASP HIS ILE CYS TYR PHE LEU TYR GLN ILE LEU ARG SEQRES 12 A 368 GLY LEU LYS TYR ILE HIS SER ALA ASN VAL LEU HIS ARG SEQRES 13 A 368 ASP LEU LYS PRO SER ASN LEU LEU LEU ASN THR THR CYS SEQRES 14 A 368 ASP LEU LYS ILE CYS ASP PHE GLY LEU ALA ARG VAL ALA SEQRES 15 A 368 ASP PRO ASP HIS ASP HIS THR GLY PHE LEU THR GLU TYR SEQRES 16 A 368 VAL ALA THR ARG TRP TYR ARG ALA PRO GLU ILE MET LEU SEQRES 17 A 368 ASN SER LYS GLY TYR THR LYS SER ILE ASP ILE TRP SER SEQRES 18 A 368 VAL GLY CYS ILE LEU ALA GLU MET LEU SER ASN ARG PRO SEQRES 19 A 368 ILE PHE PRO GLY LYS HIS TYR LEU ASP GLN LEU ASN HIS SEQRES 20 A 368 ILE LEU GLY ILE LEU GLY SER PRO SER GLN GLU ASP LEU SEQRES 21 A 368 ASN CYS ILE ILE ASN LEU LYS ALA ARG ASN TYR LEU LEU SEQRES 22 A 368 SER LEU PRO HIS LYS ASN LYS VAL PRO TRP ASN ARG LEU SEQRES 23 A 368 PHE PRO ASN ALA ASP SER LYS ALA LEU ASP LEU LEU ASP SEQRES 24 A 368 LYS MET LEU THR PHE ASN PRO HIS LYS ARG ILE GLU VAL SEQRES 25 A 368 GLU GLN ALA LEU ALA HIS PRO TYR LEU GLU GLN TYR TYR SEQRES 26 A 368 ASP PRO SER ASP GLU PRO ILE ALA GLU ALA PRO PHE LYS SEQRES 27 A 368 PHE ASP MET GLU LEU ASP ASP LEU PRO LYS GLU LYS LEU SEQRES 28 A 368 LYS GLU LEU ILE PHE GLU GLU THR ALA ARG PHE GLN PRO SEQRES 29 A 368 GLY TYR ARG SER HET F29 A1001 28 HETNAM F29 1-ALLYL-5-(2-PHENYLPYRAZOLO[1,5-A]PYRIDIN-3-YL)-1H- HETNAM 2 F29 PYRAZOLO[3,4-C]PYRIDAZIN-3-AMINE HETSYN F29 FR296110 FORMUL 2 F29 C21 H17 N7 FORMUL 3 HOH *241(H2 O) HELIX 1 1 HIS A 61 PHE A 78 1 18 HELIX 2 2 LEU A 112 GLN A 119 1 8 HELIX 3 3 SER A 122 ALA A 143 1 22 HELIX 4 4 ASP A 175 ASP A 179 5 5 HELIX 5 5 ALA A 195 ASN A 201 1 7 HELIX 6 6 LYS A 207 ASN A 224 1 18 HELIX 7 7 HIS A 232 GLY A 245 1 14 HELIX 8 8 SER A 248 ILE A 255 1 8 HELIX 9 9 ASN A 257 LEU A 267 1 11 HELIX 10 10 PRO A 274 LEU A 278 5 5 HELIX 11 11 ASP A 283 LEU A 294 1 12 HELIX 12 12 GLU A 303 HIS A 310 1 8 HELIX 13 13 PRO A 311 GLU A 314 5 4 HELIX 14 14 ASP A 318 GLU A 322 5 5 HELIX 15 15 PRO A 339 ALA A 352 1 14 HELIX 16 16 ARG A 353 GLN A 355 5 3 SHEET 1 A 2 GLU A 12 MET A 13 0 SHEET 2 A 2 VAL A 18 PHE A 19 -1 O PHE A 19 N GLU A 12 SHEET 1 B 5 TYR A 25 GLY A 32 0 SHEET 2 B 5 MET A 38 ASP A 44 -1 O SER A 41 N SER A 29 SHEET 3 B 5 VAL A 49 ILE A 56 -1 O LYS A 55 N MET A 38 SHEET 4 B 5 VAL A 101 ASP A 106 -1 O GLN A 105 N ALA A 52 SHEET 5 B 5 ILE A 86 ILE A 90 -1 N ASP A 88 O VAL A 104 SHEET 1 C 3 THR A 110 ASP A 111 0 SHEET 2 C 3 LEU A 155 LEU A 157 -1 O LEU A 157 N THR A 110 SHEET 3 C 3 LEU A 163 ILE A 165 -1 O LYS A 164 N LEU A 156 SHEET 1 D 2 VAL A 145 LEU A 146 0 SHEET 2 D 2 ARG A 172 VAL A 173 -1 O ARG A 172 N LEU A 146 CISPEP 1 GLY A 22 PRO A 23 0 -0.15 SITE 1 AC1 13 ALA A 52 LYS A 54 GLU A 71 ILE A 103 SITE 2 AC1 13 GLN A 105 ASP A 106 MET A 108 GLU A 109 SITE 3 AC1 13 THR A 110 ASN A 154 LEU A 156 ASP A 167 SITE 4 AC1 13 HOH A1124 CRYST1 48.599 68.541 59.833 90.00 110.27 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020577 0.000000 0.007599 0.00000 SCALE2 0.000000 0.014590 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017817 0.00000